Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Lilja

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2019
Clinical impact of [<sup>18</sup>F]flutemetamol PET among memory clinic patients with an unclear diagnosisAntoine Leuzy, Irina Savitcheva, Konstantinos Chiotis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2013
Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging dataRoger Lundqvist, Johan Lilja, Benjamin A Thomas, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 25, 2018
Z-score maps from low-dose <sup>18</sup>F-FDG PET of the brain in neurodegenerative dementiaDavid Fällmar, Johan Lilja, Torsten Danfors, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 18, 2015
Visual Assessment of Brain Perfusion MRI Scans in Dementia: A Pilot StudyDavid Fällmar, Johan Lilja, Vilma Velickaite, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2015
Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound BKatarzyna Adamczuk, Jolien Schaeverbeke, Natalie Nelissen, et al.
Alzheimer'S Research & Therapy|December 19, 2015
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's diseaseKatarzyna Adamczuk, Jolien Schaeverbeke, Hugo M J Vanderstichele, et al.
Acta Neuropathologica|August 21, 2018
Estimation of amyloid distribution by [<sup>18</sup>F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein depositionDietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, et al.
EJNMMI Research|May 24, 2023
Software compatibility analysis for quantitative measures of [<sup>18</sup>F]flutemetamol amyloid PET burden in mild cognitive impairmentHugh G Pemberton, Christopher Buckley, Mark Battle, et al.
Neurology|October 20, 2020
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ loadAntoine Leuzy, Johan Lilja, Christopher J Buckley, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 15, 2024
Alzheimer's disease heterogeneity revealed by neuroanatomical normative modelingFlavia Loreto, Serena Verdi, Seyed Mostafa Kia, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2019
Clinical impact of [<sup>18</sup>F]flutemetamol PET among memory clinic patients with an unclear diagnosisAntoine Leuzy, Irina Savitcheva, Konstantinos Chiotis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2013
Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging dataRoger Lundqvist, Johan Lilja, Benjamin A Thomas, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 25, 2018
Z-score maps from low-dose <sup>18</sup>F-FDG PET of the brain in neurodegenerative dementiaDavid Fällmar, Johan Lilja, Torsten Danfors, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 18, 2015
Visual Assessment of Brain Perfusion MRI Scans in Dementia: A Pilot StudyDavid Fällmar, Johan Lilja, Vilma Velickaite, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2015
Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound BKatarzyna Adamczuk, Jolien Schaeverbeke, Natalie Nelissen, et al.
Alzheimer'S Research & Therapy|December 19, 2015
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's diseaseKatarzyna Adamczuk, Jolien Schaeverbeke, Hugo M J Vanderstichele, et al.
Acta Neuropathologica|August 21, 2018
Estimation of amyloid distribution by [<sup>18</sup>F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein depositionDietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, et al.
EJNMMI Research|May 24, 2023
Software compatibility analysis for quantitative measures of [<sup>18</sup>F]flutemetamol amyloid PET burden in mild cognitive impairmentHugh G Pemberton, Christopher Buckley, Mark Battle, et al.
Neurology|October 20, 2020
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ loadAntoine Leuzy, Johan Lilja, Christopher J Buckley, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 15, 2024
Alzheimer's disease heterogeneity revealed by neuroanatomical normative modelingFlavia Loreto, Serena Verdi, Seyed Mostafa Kia, et al.
Pageof 3